CelLBxHealth

United Kingdom
Guildford, England, United Kingdom
+44 1483 685830 ★

Company profile

CelLBxHealth company profile

CelLBxHealth is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. It also owns a successful specialist technology consultancy and a major investment in a business with a unique computer graphics technology platform. The business has matured so that it now focuses on its established 90%+ owned businesses with unique high-value patent-protected medical technologies addressing multi-billion dollar markets. ANGLE's lead product is the Parsortix cell separation device, which can capture very rare circulating tumor cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
+44 1483 685830
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$1K+
Founded
1994-01-01

Headquarters

Headquarters
Guildford, England, United Kingdom
Postal code
GU2 7YD
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
4
Total equity funding
$46.8M
Last funding
Post Ipo Equity / $10.8M / 2025-11-25
Last equity funding
Post Ipo Equity / $10.8M
Investors
1
Founders
1
Articles
130
Exited on
2004-03-17

Founders and investors

Founders

Andrew Newland

Investors

Conifer Management

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.